RE:RE:80 % of AMco drugs are under 6 pounds..market is at 8 poundsI wonder if its possible that the CMA does an inquiry and finds no issue with CXR? Would look politically prudent that they addressed the issue from hyped media stories, and then put it to bed. If I were CXR and can defend my pricing strategy, I would welcome a review by CMA. Would definitely take a chunk out of short thesis and be a very positive catalyst to for the stock.